Official Title

An international, multi-site, Bayesian platform adaptive, randomized, placebo-controlled trial assessing the effectiveness of candidate interventions in preventing COVID-19 disease in healthcare workers.

Study Details

The purpose of the study is to evaluate whether the vaccine for measles, mumps and rubella (MMR) can protect front-line health-care workers against infection from SARS-CoV-2, the virus that causes COVID-19.

Principal Investigator

Dr. Michael Avidan

IRB Number



1. Participants must be 18 or older and generally healthy
2. Participants must be healthcare workers and based in a primary, secondary or tertiary healthcare setting with a high risk of developing COVID-19 due to their potential exposure to patients with SARS-CoV-2 infection

Volunteer Information

For more information about this study, contact Volunteer for Health at: